Under construction – not a live service
Sign in
CompletedNo phase

Prism Lenses with Electrical Stimulation for Neglect After Stroke

Tests prism lenses with brain stimulation in adults with neglect after stroke.

Plain-language title generated from the registry record
Registry title: Prismatic Lenses and tDCS in Neglect

Key facts

Where
Bari, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Source: NCT05842551, who can take part

Where in Italy

  • Istituti Clinici Scientifici MaugeriBari, ItalyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Istituti Clinici Scientifici Maugeri SpA
Trial code
NCT05842551
Record updated
10 November 2026
Original description
The goal of this study is to to evaluate the effect and feasibility of a rehabilitation protocol with prismatic lenses associated with tDCS, compared to a prismatic lens rehabilitation protocol associated with sham stimulation, in reducing the signs of neglect in a group of patients with spatial heminegligence following ischemic stroke of the right hemisphere.Read full original descriptionShow less

The Effect of Prismatic Lenses in Association With tDCS in Patients With Neglect: a Pilot Study

The goal of this study is to to evaluate the effect and feasibility of a rehabilitation protocol with prismatic lenses associated with tDCS, compared to a prismatic lens rehabilitation protocol associated with sham stimulation, in reducing the signs of neglect in a group of patients with spatial heminegligence following ischemic stroke of the right hemisphere.

The secondary objective is to evaluate the impact of this rehabilitation protocol on functional outcome.

Inclusion: age >18 years; ischemic stroke; hospitalization within 90 days of the event.

Exclusion: use of alchool and drugs; heamorrhagic stroke; history of neurological disease; history of psychiatric disease.

ClinicalTrials.gov NCT05842551